CTOs on the Move

BioDelivery Sciences International

www.bdsi.com

 
BioDelivery Sciences International, Inc. (NASDAQ: BDSI) is a rapidly growing commercial-stage specialty pharmaceutical company dedicated to patients living with chronic conditions. BDSI is utilizing its novel and proprietary BioErodible MucoAdhesive (BEMA®) technology and other drug delivery technologies to develop and commercialize, either on its own or in partnership with third parties, new applications of proven therapies aimed at addressing important unmet medical needs.
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million
  • www.bdsi.com
  • 4131 Parklake Avenue Suite 225
    Raleigh, NC USA 27612
  • Phone: 919.582.9050

Executives

Name Title Contact Details
Niraj Vasisht
Senior Vice President and Chief Technology Officer Profile

Funding

BioDelivery Sciences International raised $50M on 05/17/2018

Similar Companies

Merz Pharmaceuticals

Merz Pharmaceuticals is a Greensboro, NC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Health Network

Health Network is a Cranston, RI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Syntiron

Syntiron is a Saint Paul, MN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Greenrise Global Brands

Greenrise is a Canadian publicly traded corporation with its representative office located in Hamburg, Germany and operates in the medical and CBD cannabis markets in Germany.

Esperion

Esperion works hard to make our medicines easy to get, easy to take and easy to have. We discover, develop and commercialize innovative medicines and combinations to lower cholesterol, especially for patients whose needs aren`t being met by the status quo. Our entrepreneurial team of industry leaders is inclusive, passionate and resourceful. We are singularly focused on managing cholesterol so you can improve your health easily. Esperion commercializes NEXLETOL® (bempedoic acid) and NEXLIZET® (bempedoic acid and ezetimibe) Tablets and is the leader in the development of convenient oral, once-daily non-statin LDL-cholesterol lowering drugs for patients with high levels of bad cholesterol.